IL33 and non-small cell lung carcinoma: The Th2-related cytokine IL-33 has been shown to promote patient-derived NSCLC cell growth and metastasis in a nude mice model, with activation of GLUT1 and enhancement of glycolysis (Wang et al., 2016).